Trade Moderna Inc ^MRNA

FY2024 Earnings Estimate for Moderna Issued By William Blair

Berenberg Bank Sticks to Its Hold Rating for Moderna (MRNA)

How to Play Moderna Stock After the Recent Sales Guidance Cut - January 17, 2025 - Zacks.com

FY2024 EPS Estimates for Moderna Lowered by Analyst

Biotech Stock Roundup: MRNA, NTLA Down on Updates, SAGE Up on Biogen's Offer & Other Updates - January 16, 2025 - Zacks.com

CDC upgrades its advisory on bird flu. Will Moderna's stock get a boost? | Morningstar

Is Moderna (MRNA) the Stock That Will Go to the Moon According to Reddit?

Morgan Stanley Lowers Moderna (NASDAQ:MRNA) Price Target to $38.00

Analysts Issue Forecasts for Moderna FY2029 Earnings

Q4 Earnings Estimate for Moderna Issued By Leerink Partnrs

Moderna target nearly halved by Morgan Stanley on weak guidance By Investing.com

Moderna Faces Financial Uncertainty Amid Market Competition and Revenue Challenges

Healthcare: Sector Looks Undervalued with Pullback Following US Election and Obesity Data | Morningstar

Moderna Details Product Pipeline and Finances Ahead of JP Morgan Presentation

Moderna cuts 2025 sales forecast by $1B | The Manila Times

Here's Why Moderna, Inc. (MRNA) Is Among Monday's Top Losers

Moderna's mRNA Technology Looks Undervalued Despite Lower Covid Vaccine Demand | Morningstar

Moderna: Fair Value Cut Following Lower 2025 Sales Guidance and CMV Vaccine Uncertainty | Morningstar

Moderna Stock Plummets 17% on 2025 Sales Guidance Slash - January 14, 2025 - Zacks.com

Moderna (MRNA) Stock Sinks As Market Gains: Here's Why - January 14, 2025 - Zacks.com

Company News for Jan 14, 2025 - January 14, 2025 - Zacks.com

Moderna Stock Drops 20% as 2025 Outlook Falls Short of Expectations

Weak demand for RSV and COVID-19 vaccines hurt the pharmaceutical firm.

Moderna cuts 2025 sales forecast by $1 billion on weak vaccine demand

Ex-Deep Genomics, Moderna Execs Get Backing Led by Gradient to Develop Next-Generation mRNA Therapeutics with AI | Morningstar

Moderna (NASDAQ:MRNA) Sets New 52-Week Low - Here's Why

Moderna Stock Plunges 20%, But Should You Buy the Dip?

Green Alpha Advisors LLC Purchases 5,987 Shares of Moderna, Inc. (NASDAQ:MRNA)

Green Alpha Advisors LLC Acquires 5,987 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna lowers 2025 sales forecast by $1 billion

Moderna Shares Crash On Sluggish COVID Demand, Cuts 2025 Revenue Forecast

Macy's, Abercrombie and Moderna fall premarket; Sage soars By Investing.com

Moderna lowers 2025 sales forecast by $1B

Moderna updates 2025 expected revenue range to $1.5 to 2.5 billion By Investing.com

Moderna stock hits 52-week low at $33.31 amid market challenges By Investing.com

Moderna adjusts 2025 revenue outlook, shares fall By Investing.com

Moderna shares sink after vaccine maker slashes 2025 revenue outlook By Investing.com

Leverage Shares announces intraday rebalance of MRNA ETP By Investing.com

Moderna cuts 2025 sales view on slow start to RSV shot, weak COVID vaccine demand By Reuters

Moderna, Inc. (NASDAQ:MRNA) Given Consensus Recommendation of "Hold" by Analysts

Jim Cramer on Moderna, Inc. (MRNA): 'The Numbers Here Are Staggering, Staggeringly Bad'

A Norovirus Vaccine Is in the Works | TIME

News Highlights: Top Company News of the Day - Thursday at 5 AM ET | Morningstar

News Highlights: Top Company News of the Day - Thursday at 3 AM ET | Morningstar

Moderna is gambling on China as other US companies pull back | Company Business News

News Highlights: Top Company News of the Day - Thursday at 1 AM ET | Morningstar

Moderna Shares Spike on H5N1 News-What's Next for Investors? | Investing.com

Generation Bio's SWOT analysis: ctLNP tech drives pivot to autoimmune stock By Investing.com

Moderna, Inc. (NASDAQ:MRNA) Shares Purchased by Douglas Lane & Associates LLC

Moderna (NASDAQ:MRNA) Shares Down 8.9% on Analyst Downgrade

Moderna Stock Is Volatile Amid Bird Flu Developments

Moderna (NASDAQ:MRNA) Given New $96.00 Price Target at UBS Group

Moderna Stock Jumps 12%: Sell the News or Buy the Future?

Moderna Stock Skyrockets 21% as H5N1 Flu Death Sparks Vaccine Hopes and Investor Frenzy

Moderna reiterated at Market Perform by Bernstein following stock rally By Investing.com

Personalis stock target lifted, retains buy on impressive performance By Investing.com

CARDIAC DEATH of a preschool-aged child was COVERED UP in clinical trials for Moderna's omicron booster - NaturalNews.com

Why Moderna shares are rallying this week By Investing.com

Vaccine stocks rise in premarket trading amid a jump in number of flu cases By Investing.com

Moderna (MRNA) Stock Jumps 11.7%: Will It Continue to Soar? - January 8, 2025 - Zacks.com

Health Care Up as Vaccine Makers Surge - Health Care Roundup | Morningstar

Moderna: Resurgence Signals a Shift in Biotech Trends | Investing.com

Moderna Jumps 11% on Covid and Bird Flu News, Outperforming Falling Nasdaq 100

Moderna (NASDAQ:MRNA) Sees Strong Trading Volume - Here's Why

Traders Buy Large Volume of Call Options on Moderna (NASDAQ:MRNA)

Why Vaccine Stocks, Lucid (LCID) Are Rallying

Moderna, Inc. (NASDAQ:MRNA) Given Consensus Rating of "Hold" by Brokerages

Moderna stock gains on rising flu cases By Investing.com

Moderna targets 10 new approvals by 2027 By Investing.com

Vaccine developer stocks rise as flu activity escalates By Investing.com

Moderna (MRNA) Rises But Trails Market: What Investors Should Know - January 3, 2025 - Zacks.com

Moderna (NASDAQ:MRNA) Shares Up 4.5% - Here's Why

Why Moderna Inc. (MRNA) Is Skyrocketing

Tesla and Nvidia Slide Among Market Cap Stock Movers on Wednesday By Investing.com

These were the three worst stocks of 2024

Moderna (NASDAQ:MRNA) Trading 4.5% Higher - Still a Buy?

Biggest Music Moments of 2024 with Arkells' Max Kerman | Watch News Videos Online

Innovative Cancer Therapies: Key Trials and Developments

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Franklin Resources Inc.

Moderna Sees Unusually Large Options Volume (NASDAQ:MRNA)

Principal Financial Group Inc. Acquires 15,218 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna Stock Down 39% in Three Months: Buy the Dip or Wait? - December 23, 2024 - Zacks.com

Moderna (NASDAQ:MRNA) vs. Adaptive Biotechnologies (NASDAQ:ADPT) Critical Survey

Personalis shares target increased, buy rating on Merck investment By Investing.com

Moderna, Inc. (MRNA) Faces Criticism from Cramer Amid High R&D Spending and Revenue Struggles

Merck Buys $50 Million of Personalis Stock | Morningstar

Personalis secures investment from Merck, extends Moderna deal By Investing.com

Personalis, Inc. Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna By Investing.com

Moderna (NASDAQ:MRNA) Lowered to “Hold” Rating by Argus

Stifel Financial Corp Cuts Stock Position in Moderna, Inc. (NASDAQ:MRNA)

Forex Prop Trading Updates and Income Levels' Impact on Forex

Bitcoin Price Action Muted: A Complete Guide on How to Buy Bitcoins in the UK

S&P 500 and Nasdaq 100 Update: Strong Earnings Drive Market Gains

Oil price today: Oil Prices Climb Amid Supply Fears

Forex market update: GBP/USD, USD/JPY Forecast

Week Ahead: Japanese CPI and the BoJ rate hike on the watch, All eyes on the Canada inflation and Trump inauguration

Why Is the Stock Market Going Down Today and Are Interest Rates Going Down?

What Influences the Price of Heating Oil Per Gallon Today? Insights on Futures Contract Crude Oil